Taken together, a combination of traditional risk factors such as hypertension and dyslipidemia, and nontraditional ones, especially aPL, inflammation, and low anti‐PC are implicated in the increased risk of CVD in SLE. The gene discussed is FASLG; the disease is Hypertension.